RNA-binding proteins PCBP1 and PCBP2 are indispensable for B-cell development

J Immunol. 2026 Nov 2;215(11):vkag303. doi: 10.1093/jimmun/vkag303. ABSTRACT B-cell development in the bone marrow is a tightly regulated process requiring precise control of gene expression at both the transcriptional and post-transcriptional levels. Here, we identify the RNA-binding proteins PCBP1 and PCBP2 as critical regulators of early B lymphopoiesis with partially overlapping, dosage-sensitive functions. While a … Read more

T cell transcriptional landscapes are shaped by T cell receptor sequence similarity

J Immunol. 2026 Nov 2;215(11):vkag297. doi: 10.1093/jimmun/vkag297. ABSTRACT T cells exhibit high heterogeneity in both their gene expression profiles and antigen specificities, but the precise relationship between these two features remains largely unknown. Utilizing a large-scale single-cell immune profiling dataset that includes both T cell receptor (TCR) sequences and gene expression profiles of individual cells, … Read more

Cannabinoid receptor 2 promotes differentiation of T regulatory cells during allergic inflammation

J Immunol. 2026 Nov 2;215(11):vkag302. doi: 10.1093/jimmun/vkag302. ABSTRACT Allergic diseases remain a major clinical challenge because current treatments, such as antihistamines and corticosteroids, provide only symptomatic relief without addressing the underlying immune dysregulation. Induction of regulatory T cells (Tregs) to generate allergen tolerance has recently emerged as a potential form of therapy. Similarly, investigating the … Read more

VISTA deficiency drives an activated NK cell phenotype with impaired cytotoxic function

J Immunol. 2026 Nov 2;215(11):vkag282. doi: 10.1093/jimmun/vkag282. ABSTRACT Natural killer (NK) cell effector function requires coordinated receptor signaling, cytotoxic granule release, and metabolic fitness. V-domain Ig suppressor of T cell activation (VISTA) is an immune checkpoint implicated in immune regulation, but its role in NK cell biology remains incompletely defined. Using VISTA-knockout (VKO) and wild-type … Read more

Endogenous IL-33 determines the severity of Th17 cell-mediated inflammation by regulating the phenotype of antigen-presenting cells

J Immunol. 2026 Nov 2;215(11):vkag285. doi: 10.1093/jimmun/vkag285. ABSTRACT Cytokines of the interleukin (IL)-1 family are key mediators of cutaneous innate immunity. While the activation and function of IL-1β and IL-18 during immune responses are well characterized, the immunological properties of IL-33 are less well understood. The functions of exogenous IL-33, the therapeutic application of recombinant … Read more

No “Co” for CD28 in NK cells: CD28-harnessed natural killer cells mediate APC lysis independently of T-cell receptor presence or engagement

J Immunol. 2026 Nov 2;215(11):vkag313. doi: 10.1093/jimmun/vkag313. ABSTRACT Recently, primary natural killer (NK) cells have been engineered to express a transgenic T-cell receptor (NK:TCR), enabling recognition of intracellular and extracellular tumor antigens via HLA-restricted presentation. While this strategy broadens antigen specificity, NK cells lack canonical co-stimulatory receptors required for optimal T-cell activation. In T cells, … Read more

Transcriptional control of type 1 classical dendritic cell development via Irf8 super-enhancer

J Immunol. 2026 Nov 2;215(11):vkag305. doi: 10.1093/jimmun/vkag305. ABSTRACT Interferon regulatory factor 8 (IRF8) is a central transcription factor that governs the developmental program of type 1 classical dendritic cells (cDC1s). During cDC1 development, IRF8 expression continuously increases, reaching the high levels required for terminal differentiation and maintenance of cDC1 identity. Although the substantial contributions of … Read more

CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell-suppressive function in triple-negative breast cancer and other immunoregulatory settings

J Immunol. 2026 Nov 2;215(11):vkag301. doi: 10.1093/jimmun/vkag301. ABSTRACT CD71+ erythroid cells (CECs) expand in tumor-bearing hosts and suppress antitumor immunity, but the mechanisms underlying their immunoregulatory activity remain incompletely understood. Here, we identify CD39-mediated purine metabolism as a previously unrecognized suppressive pathway used by CECs. In the 4T1 model of triple-negative breast cancer, CD39 was … Read more

The development and validation of an IL-1β fate-mapping mouse unveils unexpected heterogeneity in innate immunity

J Immunol. 2026 Nov 2;215(11):vkag304. doi: 10.1093/jimmun/vkag304. ABSTRACT Interleukin-1 beta (IL-1β) is a highly proinflammatory cytokine whose synthesis and cleavage are tightly regulated. It is important for protection from several infections, but can also play a damaging role in autoimmune and autoinflammatory diseases. While pattern recognition receptor activation leads to potent induction of IL-1β, its … Read more

TNFR2 agonism increases tissue and effector Treg cells

J Immunol. 2026 Nov 2;215(11):vkag291. doi: 10.1093/jimmun/vkag291. ABSTRACT Autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus (SLE) are driven by chronic inflammation and tissue damage. Regulatory T (Treg) cells are critical for maintaining immune tolerance, yet their therapeutic use is limited by stability and tissue homing. Here, we demonstrate that agonism of tumor … Read more

deneme bonusu veren siteler - canlı bahis siteleri - casino siteleri casino siteleri deneme bonusu veren siteler canlı casino siteleri cURL Hatası: Could not resolve host: lkl.dolarkurum.com